Zacks Research Estimates Palomar's Q2 Earnings (NASDAQ:PLMR)

Key Points

• Zacks Research slightly raised Palomar’s Q2 2026 EPS estimate to $1.59 from $1.58 and lifted its FY2026 forecast to $9.87 per share, signaling a modestly improved earnings outlook.
• The firm kept a Hold rating on Palomar, even as analysts’ views remained mixed overall; the stock currently carries a consensus rating of “Moderate Buy” with an average target price of $147.75.
• Palomar recently beat Q1 earnings expectations, posting $2.31 EPS versus $2.17 expected, while revenue rose 59.7% year over year, though it came in below analyst revenue estimates.

Palomar Holdings, Inc. (NASDAQ:PLMR - Free Report) - Stock analysts at Zacks Research boosted their Q2 2026 EPS estimates for shares of Palomar in a research report issued to clients and investors on Friday, June 19th. Zacks Research analyst Team now expects that the company will post earnings of $1.59 per share for the quarter, up from their previous forecast of $1.58. Zacks Research has a "Hold" rating on the stock. The consensus estimate for Palomar's current full-year earnings is $8.99 per share. Zacks Research also issued estimates for Palomar's Q3 2026 earnings at $2.63 EPS, FY2026 earnings at $9.87 EPS, Q2 2027 earnings at $2.03 EPS, FY2027 earnings at $9.83 EPS and Q1 2028 earnings at $3.00 EPS.

Other equities research analysts have also issued reports about the company. Piper Sandler decreased their target price on Palomar from $151.00 to $132.00 and set an "overweight" rating for the company in a research report on Monday, May 11th. JPMorgan Chase & Co. cut their price target on Palomar from $160.00 to $150.00 and set an "overweight" rating on the stock in a research note on Tuesday, May 26th. Keefe, Bruyette & Woods decreased their price objective on Palomar from $186.00 to $159.00 and set an "outperform" rating for the company in a report on Wednesday, May 13th. Weiss Ratings upgraded shares of Palomar from a "hold (c)" rating to a "hold (c+)" rating in a report on Thursday, June 18th. Finally, Wall Street Zen downgraded shares of Palomar from a "buy" rating to a "hold" rating in a research report on Sunday, March 1st. Four research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $147.75.

Palomar Stock Up 4.0%

Shares of NASDAQ:PLMR opened at $116.08 on Wednesday. The business's 50 day moving average is $115.98 and its 200 day moving average is $122.37. The stock has a market cap of $3.08 billion, a P/E ratio of 16.17 and a beta of 0.44. Palomar has a 52-week low of $100.81 and a 52-week high of $162.65. The company has a quick ratio of 0.49, a current ratio of 0.49 and a debt-to-equity ratio of 0.31.

Palomar (NASDAQ:PLMR - Get Free Report) last issued its earnings results on Wednesday, May 6th. The company reported $2.31 EPS for the quarter, topping analysts' consensus estimates of $2.17 by $0.14. The business had revenue of $278.94 million for the quarter, compared to analyst estimates of $557.79 million. Palomar had a net margin of 20.11% and a return on equity of 22.62%. The company's quarterly revenue was up 59.7% compared to the same quarter last year. During the same period last year, the company posted $1.87 earnings per share.

Hedge Funds Weigh In On Palomar

Several hedge funds have recently modified their holdings of PLMR. PVG Asset Management Corp boosted its stake in Palomar by 526.4% in the 1st quarter. PVG Asset Management Corp now owns 10,147 shares of the company's stock worth $1,147,000 after purchasing an additional 8,527 shares in the last quarter. Parallel Advisors LLC raised its holdings in shares of Palomar by 638.3% in the first quarter. Parallel Advisors LLC now owns 443 shares of the company's stock worth $53,000 after buying an additional 383 shares during the last quarter. Bank of America Corp DE lifted its stake in shares of Palomar by 1.2% during the first quarter. Bank of America Corp DE now owns 146,570 shares of the company's stock worth $17,515,000 after buying an additional 1,693 shares during the period. Janus Henderson Group PLC grew its holdings in shares of Palomar by 17.4% during the first quarter. Janus Henderson Group PLC now owns 933,993 shares of the company's stock valued at $111,664,000 after buying an additional 138,368 shares during the last quarter. Finally, Amundi grew its holdings in shares of Palomar by 34.9% during the first quarter. Amundi now owns 6,283 shares of the company's stock valued at $751,000 after buying an additional 1,625 shares during the last quarter. Institutional investors and hedge funds own 90.25% of the company's stock.

Insider Buying and Selling at Palomar

In other news, CEO Mac Armstrong sold 3,500 shares of the firm's stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $114.39, for a total value of $400,365.00. Following the completion of the sale, the chief executive officer owned 332,888 shares of the company's stock, valued at $38,079,058.32. This trade represents a 1.04% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Jon Christianson sold 1,937 shares of the company's stock in a transaction dated Wednesday, April 15th. The shares were sold at an average price of $128.62, for a total value of $249,136.94. Following the transaction, the president directly owned 65,919 shares in the company, valued at $8,478,501.78. This represents a 2.85% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 15,134 shares of company stock valued at $1,896,081. Company insiders own 3.70% of the company's stock.

Trending Headlines about Palomar

Here are the key news stories impacting Palomar this week:

• Positive Sentiment: Zacks Research raised Palomar’s FY2026 EPS estimate to $9.87 from $8.99, signaling improved expected profitability.
• Positive Sentiment: The firm also nudged up Q2 2026 EPS to $1.59 and Q2 2027 EPS to $2.03, suggesting modestly better near-term earnings outlook.
• Positive Sentiment: A Zacks article included Palomar among P&C insurers expected to stay resilient during the 2026 hurricane season, which may reinforce confidence in the company’s risk profile. Article title
• Neutral Sentiment: Zacks Research maintained a Hold rating, indicating no major change in overall stance despite the estimate revisions.
• Neutral Sentiment: Some longer-dated estimates were only slightly changed, including a small Q4 2026 increase and a modest Q1 2028 reduction, which likely won’t move the stock much on their own.
• Negative Sentiment: Zacks trimmed its Q3 2026 EPS estimate to $2.63 from $2.84, and also lowered FY2027 and FY2028 forecasts, which could temper enthusiasm for Palomar’s longer-term earnings trajectory.

Palomar Company Profile

Palomar Holdings, Inc NASDAQ: PLMR is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.